BioCorteX
PrivateLast Round
Seed
Mar 28, 2023
Total Funding Raised
$5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioCorteX operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2023.
BioCorteX is a biotechnology company that operates a techbio platform to model the interactions between the microbiome, host, and treatments to de-risk the pharmaceutical pipeline.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioCorteX Comparables
Compare BioCorteX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Outpost Bio | 84% | |
| Pragma Bio | 78% | |
| QuantHealth | 71% |
For institutional investors. Book with your work email.
BioCorteX Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioCorteX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hoxton Ventures | Seed |
| Draper Associates | Seed |
| Sofinnova Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 48% MoM.
- Mar 28, 2023
$5M round led by Hoxton Ventures and Sofinnova Partners.
For institutional investors. Book with your work email.
BioCorteX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioCorteX's valuation, stock price, and market status.
Is BioCorteX a public or private company?
BioCorteX is a private company.
What is the current stock price of BioCorteX?
BioCorteX is a private company, so its shares have no public market price. Caplight tracks BioCorteX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioCorteX worth (valuation)?
Valuation information for BioCorteX is not publicly available.
Can I buy BioCorteX stock?
BioCorteX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioCorteX's last funding round?
BioCorteX's most recent funding round was Seed on March 28, 2023.
Who are the main investors in BioCorteX?
Key investors in BioCorteX include Hoxton Ventures, Sofinnova Partners.
Will BioCorteX IPO soon?
No public IPO plans have been announced for BioCorteX.
How can I track BioCorteX secondary market activity?
Caplight tracks bids, offers, and trades in BioCorteX's shares on secondary markets.